Your browser doesn't support javascript.
loading
How much does cytomegalovirus viremia matter after chimeric antigen receptor T-cell therapy?
Hammond, Sarah P; Little, Jessica S.
  • Hammond SP; Divisions of Infectious Diseases and Hematology/Oncology, Massachusetts General Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Little JS; Division of Infectious Diseases, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Clin Infect Dis ; 2024 Feb 02.
Article en En | MEDLINE | ID: mdl-38307033

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article